Contact this trialFirst, we need to learn more about you.
Immunomodulatory Agent
Leflunomide for High-Risk Smoldering Multiple Myeloma
Recruiting3 awardsPhase < 1
Duarte, California
This trial is testing how well leflunomide works for treating patients with high-risk smoldering plasma cell myeloma, to delay disease progression.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.